Anti-Diabetic Generic Pharmaceutical Supplies

Diabetes remains one of the fastest growing health conditions in the world, presenting major challenges to national health authorities seeking to contain the health impact of morbidity and mortality associated with the poor control of diabetes.

Bristol Laboratories is pleased to announce the addition of the Zicron™ brand (gliclazide 40mg) to its growing portfolio of anti-diabetic generic pharmaceuticals.

Diabetic Generic Medicines - Product Availability

To view pack sizes, formulations and drug presentations available, please click on the product name of interest for full individual product information.